Purchase Order 36C25625P0639

Award Date 2/20/25
Potential Completion Date 5/19/25
Potential Value $50K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New Orleans, LA 70119, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the provision of Novocure Inc.'s Optune Plus Transducer Therapy System to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). Novocure, a foreign-owned, for-profit manufacturer of medical devices, is the prime contractor on this $49,748.73 firm-fixed-price delivery order contract. The contract, which does not utilize any set-aside designations, was awarded on March 27, 2024, with a period of performance through June 26, 2024....
This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The $49,748.73 fixed-price delivery order is for the provision of Novocure's Optune Plus transducers, a component of the company's Tumor Treating Fields (TTFields) cancer therapy technology, over a 3-month period. This award is part of a larger $28.85 million Federal Supply Schedule (FSS)...
This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices specializing in cancer therapy. The $49,748.73 firm fixed-price delivery order is for the provision of Novocure's Optune Plus transducers, device rentals, and related support services. This award is issued under Novocure's 5-year, $28.85 million Federal Supply Schedule (FSS) contract with the VA...
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, is a delivery order issued under a $28.85 million Federal Supply Schedule (FSS) contract with the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract, valued at $49,748.73, is for the provision of Novocure's Optune transducers, device rentals, and related support services for the treatment of glioblastoma and mesothelioma at various VA medical centers...
This federal contract award to Novocure Inc., a foreign-owned manufacturer of medical devices, is for the provision of Optune Plus transducers, device rentals, and related support services to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract, valued at $49,748.73, is a Firm Fixed Price delivery order awarded under Novocure's 5-year Federal Supply Schedule (FSS) contract with the VA VHA, which has a ceiling value of $28.85 million. This multiple-award...
This federal contract award is for the provision of TRANSDUCERS to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The prime contractor is Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices specializing in cancer therapy using its proprietary Tumor Treating Fields (TTFields) technology. The $45,600.00 firm fixed-price contract has an ultimate completion date of June 9, 2025 and does not utilize any set-aside designations. Novocure...
This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The $49,748.73 firm fixed-price delivery order contract is for the provision of Novocure's Optune Plus transducers, device rentals, and related support services. This award is issued under Novocure's existing 5-year, $28.85 million Federal Supply Schedule (FSS) contract with the VA VHA, which...
This is a federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices specializing in cancer therapy using its proprietary Tumor Treating Fields (TTFields) technology. The contract, valued at $49,748.73, was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) under its Federal Supply Schedule (FSS) program. The contract is for the provision of Novocure's Optune Plus transducers, device rentals, and related...
This federal contract award to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The $45,600.00 firm fixed-price delivery order is for the provision of Novocure's Optune Plus transducers, device rentals, and related support services to VA medical centers nationwide. The contract is part of a larger 5-year Federal Supply Schedule (FSS) contract (ID: 36F79723D0016) with a...
This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Novocure Inc., a foreign-owned, for-profit manufacturer of medical devices. The $49,748.73 firm-fixed-price delivery order was awarded under Novocure's existing $28.85 million Federal Supply Schedule (FSS) contract with the VA VHA, which provides Optune Plus transducers, device rentals, and related support services for the treatment of glioblastoma and mesothelioma using...

This federal contract award is for the delivery of transducer devices to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) by the prime contractor, Novocure Inc. The contract award has a value of $49,748.73 and a completion date of May 19, 2025. Novocure is a foreign-owned, for-profit manufacturer of medical devices, specializing in cancer therapy using its proprietary Tumor Treating Fields (TTFields) technology. The contract does not utilize any set-aside designations. Novocure holds a 5-year Federal Supply Schedule (FSS) contract with the VA VHA, which provides a streamlined procurement vehicle for the VA to obtain Novocure's Optune TTFields therapy products and services. This specific award is likely a delivery order issued under the FSS contract to support the VA's mission of expanding veterans' access to cutting-edge cancer therapies, enabling VA facilities to offer Novocure's non-invasive treatment option to veteran patients diagnosed with glioblastoma, mesothelioma, and other forms of solid tumor cancers.

Generated 2/21/25, 9:32 AM